Invention Grant
- Patent Title: Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
-
Application No.: US12487486Application Date: 2009-06-18
-
Publication No.: US09751893B2Publication Date: 2017-09-05
- Inventor: Rajinder Singh , Ankush Argade , Hui Li , Somasekhar Bhamidipati , David Carroll , Catherine Sylvain , Jeffrey Clough , Holger Keim
- Applicant: Rajinder Singh , Ankush Argade , Hui Li , Somasekhar Bhamidipati , David Carroll , Catherine Sylvain , Jeffrey Clough , Holger Keim
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent Travis Young
- Main IPC: C07D417/12
- IPC: C07D417/12 ; C07D417/14 ; A61K31/541 ; A61K31/506 ; A61P19/02 ; C07D498/04 ; C07D403/12 ; C07D405/12 ; C07D405/14 ; C07D413/12 ; C07D413/14 ; C07D498/06
Abstract:
The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
Public/Granted literature
- US20090318687A1 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds Public/Granted day:2009-12-24
Information query
